F. Guilloux

603 total citations
8 papers, 539 citations indexed

About

F. Guilloux is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, F. Guilloux has authored 8 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 2 papers in Organic Chemistry. Recurrent topics in F. Guilloux's work include Neuroscience and Neuropharmacology Research (5 papers), Synthesis and pharmacology of benzodiazepine derivatives (2 papers) and Analytical Chemistry and Chromatography (2 papers). F. Guilloux is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Synthesis and pharmacology of benzodiazepine derivatives (2 papers) and Analytical Chemistry and Chromatography (2 papers). F. Guilloux collaborates with scholars based in . F. Guilloux's co-authors include G. Le Fur, A. Uzan, C. Guérémy, M.C. Dubroeucq, C. Renault, Jesús Bénavidès, J Mizoule, Pierre Rufat, Gérard Le Fur and André Uzan and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology and Life Sciences.

In The Last Decade

F. Guilloux

8 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Guilloux 8 371 217 80 64 60 8 539
J Mizoule 6 370 1.0× 177 0.8× 84 1.1× 43 0.7× 96 1.6× 10 543
Steven Culp United States 13 431 1.2× 325 1.5× 87 1.1× 40 0.6× 40 0.7× 21 755
Kathleen Hauser Switzerland 11 433 1.2× 313 1.4× 44 0.6× 81 1.3× 52 0.9× 25 619
Stephen I. Deutsch United States 12 256 0.7× 180 0.8× 85 1.1× 44 0.7× 76 1.3× 17 482
Elizabeth Erdelyi United States 12 396 1.1× 307 1.4× 69 0.9× 88 1.4× 49 0.8× 21 678
Hiroyasu Tanaka Japan 15 394 1.1× 282 1.3× 26 0.3× 46 0.7× 56 0.9× 56 639
G.E. Martin United States 17 483 1.3× 254 1.2× 27 0.3× 99 1.5× 70 1.2× 34 732
Maggie D. Lalies United Kingdom 12 315 0.8× 247 1.1× 51 0.6× 75 1.2× 31 0.5× 17 492
Takeo Funakoshi Japan 15 301 0.8× 321 1.5× 66 0.8× 84 1.3× 57 0.9× 22 763
Shu‐chi Hsiung United States 16 351 0.9× 326 1.5× 56 0.7× 56 0.9× 64 1.1× 20 661

Countries citing papers authored by F. Guilloux

Since Specialization
Citations

This map shows the geographic impact of F. Guilloux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Guilloux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Guilloux more than expected).

Fields of papers citing papers by F. Guilloux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Guilloux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Guilloux. The network helps show where F. Guilloux may publish in the future.

Co-authorship network of co-authors of F. Guilloux

This figure shows the co-authorship network connecting the top 25 collaborators of F. Guilloux. A scholar is included among the top collaborators of F. Guilloux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Guilloux. F. Guilloux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Dubroeucq, M.C., Jesús Bénavidès, Adam Doble, et al.. (1986). Stereoselective inhibition of the binding of [3H]PK 11195 to peripheral-type benzodiazepine binding sites by a quinolinepropanamide derivative. European Journal of Pharmacology. 128(3). 269–272. 31 indexed citations
2.
Bénavidès, Jesús, F. Guilloux, A. Uzan, et al.. (1984). Opposite effects of an agonist, R05-4864, and an antagonist, PK 11195, of the peripheral type benzodiazepine binding sites on audiogenic seizures in DBA/2J mice. Life Sciences. 34(26). 2613–2620. 92 indexed citations
3.
Bénavidès, Jesús, F. Guilloux, Pierre Rufat, et al.. (1984). In vivo labelling in several rat tissues of ‘peripheral type’ benzodiazepine binding sites. European Journal of Pharmacology. 99(1). 1–7. 41 indexed citations
4.
Fur, G. Le, F. Guilloux, Pierre Rufat, et al.. (1983). Peripheral benzodiazepine binding sites: Effect of PK 11195, 1-(2-chlorophenyl)-n-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. Life Sciences. 32(16). 1849–1856. 204 indexed citations
5.
Fur, G. Le, F. Guilloux, & A. Uzan. (1983). Evidence for an Increase in [3H]Spiperone Binding in Hypothalamic Nuclei During the Development of Spontaneous Hypertension in the Rat. Clinical and Experimental Hypertension Part A Theory and Practice. 5(9). 1537–1542. 7 indexed citations
6.
Fur, Gérard Le, et al.. (1981). Central dopaminergic neurons during development of genetic and doca-salt hypertension in the rat. Developmental Brain Research. 1(2). 153–163. 36 indexed citations
7.
Fur, Gérard Le, F. Guilloux, & André Uzan. (1980). In vivo blockade of dopaminergic receptors from different rat brain regions by classical and atypical neuroleptics. Biochemical Pharmacology. 29(3). 267–270. 22 indexed citations
8.
Fur, G. Le, et al.. (1979). Relationships between plasma corticosteroids and benzodiazepines in stress.. Journal of Pharmacology and Experimental Therapeutics. 211(2). 305–308. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026